MV Capital Management’s Roivant Sciences ROIV Stock Holding History

MV Capital Management’s Portfolio ROIV Stock Details ROIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.34K	Sell	38 -2	-5%	-$59	﹤0.01%	855
2026 Q1	$1.11K	Buy	40 +2	+5%	+$51	﹤0.01%	849
2025 Q4	$825	Buy	38 +1	+3%	+$20	﹤0.01%	854
2025 Q3	$560	Hold	37	–	–	﹤0.01%	854
2025 Q2	$417	Buy	+37	New	+$401	﹤0.01%	870
2025 Q1	–	Sell	-13	Closed	-$154	–	1088
2024 Q4	$154	Buy	13 +9	+225%	+$106	﹤0.01%	922
2024 Q3	$47	Sell	4 -3	-43%	-$34	﹤0.01%	1025
2024 Q2	$74	Buy	+7	New	+$77	﹤0.01%	924

Other funds holding ROIV

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

MV Capital Management's ROIV Position: Q2 2026 in Review

MV Capital Management reduced its Roivant Sciences (ROIV) stake by 5% in Q2 2026, selling an estimated $59 and leaving 38 shares worth $1.34K. The position accounts for ﹤0.01% of the portfolio, ranked #855.

MV Capital Management first reported a position in ROIV in Q2 2024 and has held it in 8 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

MV Capital Management held 38 shares of Roivant Sciences worth $1.34K as of Q2 2026.
MV Capital Management sold 2 Roivant Sciences shares in Q2 2026, an estimated $59.
Roivant Sciences made up ﹤0.01% of MV Capital Management's portfolio in Q2 2026, its #855 holding.
MV Capital Management first reported a position in Roivant Sciences in Q2 2024 and has held it in 8 quarters since.
498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on MV Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.